Mucosal vaccination is a revolutionary method for controlling epidemic and pandemic infectious ailments. The technique has an exclusive feature that makes it produce very strong immune responses to pathogens at the entry point. This section gives detailed information on mucosal immunity and its importance in protection against different diseases. It starts by probing into how mucosal immune responses work before presenting arguments that support mucosal vaccination choices over other options. In addition, the chapter provides a contrast between traditional systemic inoculation ways. It shows the superiority and wider range of action of mucosal vaccines when compared with traditional systemic vaccination routes. Detailed scrutiny of manifold mucosal vaccine delivery systems comprising oral, nasal, and pulmonary routes discloses various ways to overcome mucosal barriers and improve the uptake and efficiency of vaccines. The chapter presents success stories of preventing infectious diseases, including influenza, rotavirus, and cholera, through mucosal vaccination, as seen in preclinical and clinical studies. It also identifies complexities within the regulatory environment for a better understanding of those unique obstacles, which ought to be considered when seeking approval for a new type of vaccine, like one that is administered through mucosal routes. The chapter underscores the realworld impact of mucosal vaccination on the disease burden and the shaping of public health outcomes with insightful case studies. However, despite considerable progress made in this field, it is still confronted by various difficulties in the selection of antigens and optimization of formulations, as well as scaling up production. This paper also describes essential scientific tracks for future research along with some technological advancements that are considered to overcome these impediments and open a gateway for a new generation of mucosal vaccines. In summary, this chapter emphasizes the long-term investments and partnerships that are needed to optimize mucosal vaccination as a major approach to addressing emerging and pandemic infectious diseases. This way, we can build up our ability to protect ourselves by encouraging prevention measures at the mucosal level.
Keywords: Emerging diseases, Mucosal immunity, Pandemic, Regulatory approval, Vaccine delivery systems, Vaccination.
